Corrado Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Corrado Advisors’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-333	Closed	-$24K	–	106
2018 Q3	$24K	Sell	333 -134	-29%	-$8.84K	0.02%	100
2018 Q2	$38K	Buy	+467	New	+$45.1K	0.02%	107

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Corrado Advisors's VBIV Position: Q4 2018 in Review

Corrado Advisors sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2018, closing a stake of 333 shares — an estimated $24K sold.

Corrado Advisors first reported a position in VBIV in Q2 2018 and held it in 2 quarters. The position peaked at $38K in Q2 2018. 40 funds tracked by Wall St. Rank hold VBIV as of Q4 2018.

Corrado Advisors reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2018 after selling out during the quarter.
Corrado Advisors sold 333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2018, an estimated $24K.
Corrado Advisors first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2018 and held it in 2 quarters.
Corrado Advisors's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $38K in Q2 2018.
40 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2018.

Based on Corrado Advisors's 13F filing for Q4 2018, filed 9 Jan 2019.